ATE89007T1 - Von monozyten abstammendes gefaesswirksames protein und dessen analogen, verfahren zu seiner gewinnung und ihre verwendungen fuer therapeutische zwecke und zur antikoerperherstellung. - Google Patents

Von monozyten abstammendes gefaesswirksames protein und dessen analogen, verfahren zu seiner gewinnung und ihre verwendungen fuer therapeutische zwecke und zur antikoerperherstellung.

Info

Publication number
ATE89007T1
ATE89007T1 AT88402068T AT88402068T ATE89007T1 AT E89007 T1 ATE89007 T1 AT E89007T1 AT 88402068 T AT88402068 T AT 88402068T AT 88402068 T AT88402068 T AT 88402068T AT E89007 T1 ATE89007 T1 AT E89007T1
Authority
AT
Austria
Prior art keywords
production
protein
derived
thr
ser
Prior art date
Application number
AT88402068T
Other languages
English (en)
Inventor
Jean-Luc Wautier
Original Assignee
Inst Vaisseaux Et Du Sang
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inst Vaisseaux Et Du Sang filed Critical Inst Vaisseaux Et Du Sang
Application granted granted Critical
Publication of ATE89007T1 publication Critical patent/ATE89007T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/22—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against growth factors ; against growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Vascular Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Urology & Nephrology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT88402068T 1987-08-12 1988-08-09 Von monozyten abstammendes gefaesswirksames protein und dessen analogen, verfahren zu seiner gewinnung und ihre verwendungen fuer therapeutische zwecke und zur antikoerperherstellung. ATE89007T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8711490A FR2619383B1 (fr) 1987-08-12 1987-08-12 Proteine a activite vasculaire, derivee des monocytes et ses analogues, procede pour son extraction et leurs utilisations en therapeutique et pour la preparation d'anticorps
EP88402068A EP0303538B1 (de) 1987-08-12 1988-08-09 Von Monozyten abstammendes gefässwirksames Protein und dessen Analogen, Verfahren zu seiner Gewinnung und ihre Verwendungen für therapeutische Zwecke und zur Antikörperherstellung

Publications (1)

Publication Number Publication Date
ATE89007T1 true ATE89007T1 (de) 1993-05-15

Family

ID=9354140

Family Applications (1)

Application Number Title Priority Date Filing Date
AT88402068T ATE89007T1 (de) 1987-08-12 1988-08-09 Von monozyten abstammendes gefaesswirksames protein und dessen analogen, verfahren zu seiner gewinnung und ihre verwendungen fuer therapeutische zwecke und zur antikoerperherstellung.

Country Status (6)

Country Link
US (1) US5071956A (de)
EP (1) EP0303538B1 (de)
JP (1) JPH01104100A (de)
AT (1) ATE89007T1 (de)
DE (1) DE3880758T2 (de)
FR (1) FR2619383B1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9312315D0 (en) * 1993-06-15 1993-07-28 Poston Robin Leukocyte adhesion assay
US5441986A (en) * 1994-07-19 1995-08-15 Pfizer Inc. Estrogen agonists as remedies for prostate and cardiovascular diseases
US8697139B2 (en) 2004-09-21 2014-04-15 Frank M. Phillips Method of intervertebral disc treatment using articular chondrocyte cells

Also Published As

Publication number Publication date
EP0303538B1 (de) 1993-05-05
JPH01104100A (ja) 1989-04-21
FR2619383A1 (fr) 1989-02-17
EP0303538A2 (de) 1989-02-15
US5071956A (en) 1991-12-10
DE3880758D1 (de) 1993-06-09
EP0303538A3 (en) 1989-03-29
DE3880758T2 (de) 1993-08-19
FR2619383B1 (fr) 1989-12-08

Similar Documents

Publication Publication Date Title
Langeveld et al. Structural heterogeneity of the noncollagenous domain of basement membrane collagen.
EP0751992A4 (de) Vaskularer endothelialer wachstumsfaktor 2
ATE352559T1 (de) Verfahren zur verminderung der immunogenität von proteinen
JPH03500046A (ja) フィブロネクチン活性を有するポリペプチド
ATE170630T1 (de) Proteine mit geänderten epitopen und verfahren zur deren herstellung
ATE140963T1 (de) Verfahren zur herstellung von sekretierten rezeptoranalogen
CA2290485A1 (en) Method for the production of non-immunogenic proteins
DE3588254D1 (de) Gag-Antigen und dessen Verwendung zum Nachweis von LAV-Infektion, sowie in immunogenen Zusammensetzungen
EP1064308A4 (de) Verfahren zur identifizierung von induktoren und inhibitoren proteolytischer antikörper, zusammensetzungen sowie deren verwendungen
DE68925226D1 (de) Monoklonale Antikörper
PL274485A1 (en) Method of obtaining stable preparations of human proteins
ATE238065T1 (de) Peptide zur verwendung in impfung und anregung von antikörperbildung gegen menschliches immunschwäche virus
ATE265226T1 (de) Verwendung von wolinella succinogenes asparaginase zur behandlung von asparagin- abhängiger krankheiten
ATE395081T1 (de) Lo-cd2a antikörper und dessen verwendungen zur hemmung von t-zell aktivierung und wachstum
KR900002795A (ko) 하이브리드 단백질c 작제물 및 그들의 제조방법
HUP0100456A1 (hu) IFNAR2/IFN komplex, alkalmazásai és a komplexet tartalmazó készítmények
EE05497B1 (et) Polüpeptiid, lahustuv CRAM-1 polüpeptiid, polünukleotiid ja antikeha
RU94045907A (ru) Вич-антитела человека или их фрагменты, экспрессионные кассеты, клетки-хозяева, фармацевтические композиции, способ защиты
DE69633393D1 (de) Mitteln zur behandlung von auto-immun krankheiten
DE69233245D1 (de) Verfahren zur Herstellung von Peptiden
DE3880758D1 (de) Von monozyten abstammendes gefaesswirksames protein und dessen analogen, verfahren zu seiner gewinnung und ihre verwendungen fuer therapeutische zwecke und zur antikoerperherstellung.
DK0683791T3 (da) Vandig proteinsammensætning, glycoprotein indeholdt deri, fremgangsmåde til opnåelse deraf og anvendelser deraf
ATE151777T1 (de) Modifizierter plättchenfaktor-4
ATE162799T1 (de) Peptide mit thiolgeschütztem cystein zur verwendung in immuntests
DK0426314T3 (da) HIV-relaterede peptider

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties